3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
2
Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
TP53 Y220C Mutation
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Overweight
1
Osteosarcoma
1
Obesity
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Multiple Myeloma
1
Motor Activity
1
Mesothelioma
1
Meningioma
1
Medulloblastoma
1
Interventions
asciminib
8
Dasatinib
7
nilotinib
6
Imatinib Mesylate
5
Cyclophosphamide
4
ponatinib
3
fludarabine phosphate
3
bosutinib
3
Whole-Body Irradiation
3
ruxolitinib
2
letermovir
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Melphalan
2
Cyclosporine
2
Busulfan
2
venetoclax
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
decitabine and cedazuridine drug combination
1
Vorinostat
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
Tablets
×
1 year
×
Clear all
No trials found.